Findings Support Commencement of VAL-083’s Participation in Pivotal GCAR GBM AGILE Study SAN DIEGO, June 22, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused… Read More
NL-201 demonstrates durable antitumor activity in animal tumor models – – NL-201 and targeted variants improve outcomes when combined with CAR-T cells in vivo – – Conditional activation of de novo… Read More
Vancouver, BC – June 19, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
Ottawa, June 19, 2020 – Innovative Medicines Canada released the following statement today in response to the release of revised PMPRB pricing guidelines: “We have just received the revised Guidelines and we… Read More
June 2, 2020 – Ottawa, Ontario The Government of Canada recognizes that a smooth economic recovery will require continued collaboration between the public and private sectors in the wake of… Read More
